Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2013
Molecular pathways: PI3K pathway targets in triple-negative breast cancers
Vallerie Gordon, Shantanu Banerji
Cancer Biology & Therapy
|
September 14, 2006
Important differences between topoisomerase-I and -II targeting agents
Shantanu Banerji, Marek Los
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 24, 2017
Immune Signatures of Non-Small Cell Lung Cancer
Susan Green, David E Dawe, Shantanu Banerji
Nature
|
April 17, 2015
Pugh et al. reply
Trevor J Pugh, Shantanu Banerji, Matthew Meyerson
Cancer Treatment and Research Communications
|
September 13, 2018
Benefit of crizotinib in a lung cancer patient with discordant ALK testing results
Steven Grocholski, Shantanu Banerji, Gefei Qing, et al.
JTO Clinical and Research Reports
|
February 24, 2025
Cannabidiol Vaping-Associated Multifocal NSCLC in a 24-Year-Old Female: A Case Report
Mansi Barthwal, Nataliya Moldovan, Shantanu Banerji, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
Shantanu Banerji, Daniel E Meyers, Craig Harlos, et al.
Current Oncology (Toronto, Ont.)
|
September 27, 2024
Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Under-Represented by Clinical Trials
Daniel E Meyers, Rebekah Rittberg, David E Dawe, et al.
Cureus
|
December 3, 2020
Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
Rebekah Rittberg, Shantanu Banerji, Susan Green, et al.
American Journal of Clinical Oncology
|
October 10, 2021
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer
Rebekah Rittberg, Shantanu Banerji, Julian O Kim, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2013
Molecular pathways: PI3K pathway targets in triple-negative breast cancers
Vallerie Gordon, Shantanu Banerji
Cancer Biology & Therapy
|
September 14, 2006
Important differences between topoisomerase-I and -II targeting agents
Shantanu Banerji, Marek Los
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 24, 2017
Immune Signatures of Non-Small Cell Lung Cancer
Susan Green, David E Dawe, Shantanu Banerji
Nature
|
April 17, 2015
Pugh et al. reply
Trevor J Pugh, Shantanu Banerji, Matthew Meyerson
Cancer Treatment and Research Communications
|
September 13, 2018
Benefit of crizotinib in a lung cancer patient with discordant ALK testing results
Steven Grocholski, Shantanu Banerji, Gefei Qing, et al.
JTO Clinical and Research Reports
|
February 24, 2025
Cannabidiol Vaping-Associated Multifocal NSCLC in a 24-Year-Old Female: A Case Report
Mansi Barthwal, Nataliya Moldovan, Shantanu Banerji, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
Shantanu Banerji, Daniel E Meyers, Craig Harlos, et al.
Current Oncology (Toronto, Ont.)
|
September 27, 2024
Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Under-Represented by Clinical Trials
Daniel E Meyers, Rebekah Rittberg, David E Dawe, et al.
Cureus
|
December 3, 2020
Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
Rebekah Rittberg, Shantanu Banerji, Susan Green, et al.
American Journal of Clinical Oncology
|
October 10, 2021
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer
Rebekah Rittberg, Shantanu Banerji, Julian O Kim, et al.
Page
of 5